Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!

@article{Scarpignato2012PoorEO,
  title={Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!},
  author={Carmelo Scarpignato},
  journal={Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society},
  year={2012},
  volume={24 8},
  pages={697-704}
}
Despite acid secretion being normal in the majority of patients with gastro-esophageal reflux disease (GERD) or Barrett's esophagus, acid inhibition represents the mainstay of treatment for both these conditions, with the aim of reducing the aggressive nature of the refluxate toward the esophageal mucosa. Proton pump inhibitors (PPIs) represent, therefore, the first choice medical treatment for GERD, in that they are able to provide an 80-85% healing rate for esophageal lesions, a 56-76… CONTINUE READING
19 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…